Xybion Releases Xybion's Pristima Suite™ Version 7

News provided by

Nov 11, 2014, 08:00 ET

MORRIS PLAINS, N.J., Nov. 11, 2014 /PRNewswire/ -- Xybion is pleased to announce the release of Pristima Version 7, the most powerful solution directed at Safety Assessment, Safety Pharmacology and Early Discovery. This highly anticipated release encapsulates an architectural improvement, new modules and a large number of improvements and refinements proposed by Xybion's growing user community.

New products such as Savante™ and Histology module further evidence Xybion's mission to connect the labs and users into a single fully integrated system designed and developed by a single solution provider. Pristima 7 covers the entire life cycle of a research study from study proposal, to management of practically all aspects of a study from formulation to in-vivo data to clinical pathology to pathology and study report creation and assembly. A single product suite, from a sole provider, Pristima fulfills the entire scope, enabling a significant advantage in data integrity, data analyses and cost efficiency.

Some of the key features of Pristima 7 include:

Savante™– Pristima's Data Repository, designed to aggregate data from many sources and providing it in a fashion where clients utilizing business analytics toolsets can easily consume and evaluate the data.
Histology – the first solution on the market that integrates all aspects of the accountability, blocking, embedding, cutting, staining, chain of custody and archival of slides in a step-by-step fashion; fulfilling all aspects of GLP and 21 CFR Part 11. This web-based module includes labeling, barcode-scanning, electronic signatures and full support for tablet devices.
Improvements to the Pristima Resource Management Module, which now supports the concept of assigning teams to studies and viewing daily workloads by teams rather than individuals; a significant improvement for large, global organizations. Additionally, the Resource Management Module features the ability to create resources that are commonly limited such as telemetry devices, special-purpose rooms, etc… and to manage these resources through a reservation system.
Pharmacy improvements to further facilitate and capture the formulation data electronically.
Architectural shift from Apache to JBOSS 64 bit; a transition welcomed by enterprise IT.
WS-Trust user authentication – enabling large corporations to utilize Pristima on a SaaS basis without introducing new user ID's and passwords to their users
New clinical pathology instrument interfaces extending Xybion's market-leading position in this area.
New report tables and statistical methods – a wide variety of tables for numerical and categorical data were added with new statistical methods.

Carlos Frade, Vice-President of R&D Solutions at Xybion stated, "This release is the culmination of a demanding and successful development cycle where market analyses, client requirements, regulatory requirements and strategic partnerships with the largest pharma's and CRO's in the world all contributed dramatically to our work." Dr. Pradip Banerjee was quoted, "Pristima 7 further separates itself from any other product in the market; it is the only product on the market with such a wide scope of functional coverage while being completely developed and supported by a single vendor." Dr. Banerjee continued, "Achieving the level of integration provided by Pristima is such a dramatic and important concept to an industry historically oriented towards silos of data."

ABOUT XYBION
Xybion is the leading provider of software, services and consulting for global corporations operating in highly regulated industries. Our unique solutions focus on integrated preclinical lab management, early-stage drug discovery, regulatory compliance, GRC, quality management and systems validation.

Xybion's combination of software, business process management, services, validation and staffing enables us to cover a broad spectrum of critical business needs for companies and we deliver our solutions on global scale. Our leadership in this dynamic and ever-changing industry has been a cornerstone of our high-value reputation.